Started By
Message

re: Gilead remdesivir study published in NEJM: two third of severe ill patients improved

Posted on 4/10/20 at 8:31 pm to
Posted by ABearsFanNMS
Formerly of tLandmass now in Texas
Member since Oct 2014
17515 posts
Posted on 4/10/20 at 8:31 pm to
quote:

The media will praise this one because it is patented and gilead stands to gain a lot of money from it unlike HCQ.



Exactly what I was thinking.
first pageprev pagePage 1 of 1Next pagelast page
refresh

Back to top
logoFollow TigerDroppings for LSU Football News
Follow us on Twitter, Facebook and Instagram to get the latest updates on LSU Football and Recruiting.

FacebookTwitterInstagram